AAOS2018: TXA effective in operative management for high-energy pelvic and femoral fractures
Use of Tranexamic Acid in High-Energy Fractures of the Pelvis and Femur
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
84 patients with a high-energy fracture of the pelvis or femur and scheduled for open reduction and internal fixation were randomized to perioperative intravenous tranexamic acid (TXA) or no tranexamic acid (control). Patients were assessed for calculated total blood loss, transfusion rate, number of units transfused, postoperative drop in hematocrit, and incidence of venous thromboembolic complic...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE